Impact of glucagon response on early postprandial glucose excursions irrespective of residual β‐cell function in type 1 diabetes: A cross‐sectional study using a mixed meal tolerance test

Ultra rapid lispro improves postprandial glucose control compared with lispro in patients with type 1 diabetes: Results from the 26‐week PRONTO‐T1D study

(2020) Leslie Klaff et al.   DIABETES OBESITY & METABOLISM

Inappropriate glucagon and GLP-1 secretion in individuals with long-standing type 1 diabetes: effects of residual C-peptide

(2019) Charles Thivolet et al.   DIABETOLOGIA

Impaired early‐phase suppression of glucagon secretion after glucose load is associated with insulin requirement during pregnancy in gestational diabetes

(2019) Ichiro Horie et al.   Journal of Diabetes Investigation

Glutaminostatin: Another facet of glucagon as a regulator of plasma amino acid concentrations

(2019) Yoshitaka Hayashi   Journal of Diabetes Investigation

Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes

(2019) Sue A. Brown et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and safety of fast-acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): A 52-week, randomized, treat-to-target, phase III trial

(2018) Chantal Mathieu et al.   DIABETES OBESITY & METABOLISM

Possible Ways to Improve Postprandial Glucose Control in Type 1 Diabetes

(2018) Halis Kaan Akturk et al.   Diabetes Technology & Therapeutics

Regulation of amino acid metabolism and α-cell proliferation by glucagon

(2018) Yoshitaka Hayashi et al.   Journal of Diabetes Investigation

Control of Postprandial Hyperglycemia in Type 1 Diabetes by 24-Hour Fixed-Dose Coadministration of Pramlintide and Regular Human Insulin: A Randomized, Two-Way Crossover Study

(2018) Matthew C. Riddle et al.   DIABETES CARE

Pramlintide but Not Liraglutide Suppresses Meal-Stimulated Glucagon Responses in Type 1 Diabetes

(2017) Alfonso Galderisi et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Postprandial glucose and healthcare resource use: a cross-sectional survey of adults with diabetes treated with basal-bolus insulin

(2017) Kathryn M. Pfeiffer et al.   JOURNAL OF MEDICAL ECONOMICS

The biology of glucagon and the consequences of hyperglucagonemia

(2016) Nicolai J Wewer Albrechtsen et al.   Biomarkers in Medicine

Insulin Resistance Is Accompanied by Increased Fasting Glucagon and Delayed Glucagon Suppression in Individuals With Normal and Impaired Glucose Regulation

(2016) Kristine Færch et al.   DIABETES

Fall in C-Peptide During First 4 Years From Diagnosis of Type 1 Diabetes: Variable Relation to Age, HbA 1c , and Insulin Dose

(2016) Wei Hao et al.   DIABETES CARE

Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: The ADJUNCT TWO Randomized Trial

(2016) Bo Ahrén et al.   DIABETES CARE

Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial

(2016) Chantal Mathieu et al.   DIABETES CARE

Impact of Fat, Protein, and Glycemic Index on Postprandial Glucose Control in Type 1 Diabetes: Implications for Intensive Diabetes Management in the Continuous Glucose Monitoring Era

(2015) Kirstine J. Bell et al.   DIABETES CARE

Early phase glucagon and insulin secretory abnormalities, but not incretin secretion, are similarly responsible for hyperglycemia after ingestion of nutrients

(2015) Daisuke Yabe et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Evolution of Abnormal Plasma Glucagon Responses to Mixed-Meal Feedings in Youth With Type 1 Diabetes During the First 2 Years After Diagnosis: Figure 1

(2014) Jennifer Sherr et al.   DIABETES CARE

The influence of glucagon on postprandial hyperglycaemia in children 5 years after onset of type 1 diabetes

(2014) Siri Fredheim et al.   DIABETOLOGIA

Hyperglucagonaemia analysed by glucagon sandwich ELISA: nonspecific interference or truly elevated levels?

(2014) Nicolai J. Wewer Albrechtsen et al.   DIABETOLOGIA

Glucagon responses to increasing oral loads of glucose and corresponding isoglycaemic intravenous glucose infusions in patients with type 2 diabetes and healthy individuals

(2014) Jonatan I. Bagger et al.   DIABETOLOGIA

Specificity and sensitivity of commercially available assays for glucagon and oxyntomodulin measurement in humans

(2014) Monika J Bak et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Acute Metabolic Effects of Exenatide in Patients With Type 1 Diabetes With and Without Residual Insulin to Oral and Intravenous Glucose Challenges

(2013) Tara Ghazi et al.   DIABETES CARE

Lack of Association Between Residual Insulin Production and Glucagon Response to Hypoglycemia in Youth With Short Duration of Type 1 Diabetes

(2013) J. Sherr et al.   DIABETES CARE

Glucagon Response to Oral Glucose Challenge in Type 1 Diabetes: Lack of Impact of Euglycemia

(2013) Caroline K. Kramer et al.   DIABETES CARE

Glucose regulation of glucagon secretion

(2013) Erik Gylfe et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover

(2012) Roger H. Unger et al.   JOURNAL OF CLINICAL INVESTIGATION

Antidiabetic Actions of Endogenous and Exogenous GLP-1 in Type 1 Diabetic Patients With and Without Residual  -Cell Function

(2011) U. Kielgast et al.   DIABETES

Japanese Dietary Lifestyle and Cardiovascular Disease

(2011) Norio Tada et al.   Journal of Atherosclerosis and Thrombosis

Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus

(2010) et al.   Journal of Diabetes Investigation

Insulin Signaling in α Cells Modulates Glucagon Secretion In Vivo

(2009) Dan Kawamori et al.   Cell Metabolism

Too Much Glucagon, Too Little Insulin: Time course of pancreatic islet dysfunction in new-onset type 1 diabetes

(2008) R. J. Brown et al.   DIABETES CARE